Raj K. Puri
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Raj K.
Puri currently works at Iovance Biotherapeutics, Inc., as Chief Regulatory Officer from 2024.
Dr. Puri also formerly worked at Center for Biologics Evaluation & Research, as Director-Division Cellular.
Dr. Puri received his doctorate degree from Universidad Autónoma de Ciudad Juárez.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 248 114 ( 0,06 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Conseiller Juridique Général | 26/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Universidad Autónoma de Ciudad Juárez
Universidad Autónoma de Ciudad Juárez Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national